Courtney O’Konek | Senior Director, Corporate Communications & IR |
Mark Enyedy | President, CEO & Director |
Anna Berkenblit | SVP & Chief Medical Officer |
John Newman | Canaccord Genuity |
Earl DeSouza | H.C. Wainwright & Co. |
Kennen MacKay | RBC Capital Markets |
Tsan-Yu Hsieh | William Blair & Company |
Biren Amin | Jefferies |
David Ruch | SVB Leerink |
Michael Schmidt | Guggenheim Securities |
Jessica Fye | JPMorgan Chase & Co. |
Good morning, and welcome to the ImmunoGen's First Quarter 2020 Financial and Operating Results Call. Today's conference is being recorded.
At this time, I'd like to turn the call over to Courtney O'Konek, Senior Director of Corporate Communications and Investor Relations. Please go ahead.
Good morning, and thank you for joining today's call.